When looking at this week’s movers and shakers on the Street, Cantor analysts are backing their Buys on Oncomed Pharmaceuticals Inc (NASDAQ:OMED) and …
Shares of biotech companies Oncomed Pharmaceuticals Inc (NASDAQ:OMED) and OvaScience Inc (NASDAQ:OVAS) fell sharply today following clinical trial setback and analyst downgrade, respectively. Let’s take a look and see …
